MarketBeat published average ratings and price targets for Kalaris Therapeutics, while Citigroup reaffirmed an outperform rating and TD Cowen initiated coverage with a buy rating.
1 report, 1 independent
Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat published average ratings and price targets for Kalaris Therapeutics, while Citigroup reaffirmed an outperform rating and TD Cowen initiated coverage with a buy rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
TD Cowen
American investment bank
-
Citigroup
American investment bank and financial services corporation
Related events
- TD Cowen, Stephens, Citigroup, and MarketBeat provided new analyst ratings and coverage for Covenant Logistics Group, Inc.
- Analyst firms Jefferies and TD Cowen upgraded their ratings for Forgent Power Solutions, Inc., while MarketBeat provided consensus data.
- MarketBeat provided an average rating and target price for Tenaya Therapeutics.
- MarketBeat reports consensus rating, Citigroup restates a market outperform rating, and Jefferies Financial Group sets a $28.00 target price for Four Corners Property Trust.
- TD Cowen provides investment banking coverage for UiPath, MarketBeat aggregates consensus ratings, and CEO Daniel Dines sold company shares.